Charles River Laboratories International, Inc.
CRL
#1543
Rank
$14.214 B
Marketcap
United States
Country
$295.10
Share price
4.65%
Change (1 day)
74.16%
Change (1 year)
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use…
Key Metrics
Trailing P/E
—
Forward P/E
21.55
EPS (TTM)
$-4.81
Forward EPS
$12.69
Price / Book
4.60
EV / EBITDA
18.8x
Beta
1.41
Dividend Yield
—
Return on Equity
-7.52%
Return on Assets
4.11%
Debt / Equity
105.05
Current Ratio
1.35
Gross Margin
34.59%
Operating Margin
15.11%
Net Profit Margin
-5.96%
Free Cash Flow
$468.856M
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 18 – Sep 16
-2.07%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$4.015B
Latest Net Income$-144,338,000
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Charles River Laboratories International, Inc. with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
CRL
No recent news available. Set FINNHUB_API_KEY to enable news.
